Toxoplasmosis in Cats: Clinical Signs, Diagnosis, and Zoonotic Risk

Etiology and Life Cycle

Toxoplasmosis is caused by the obligate intracellular protozoan parasite Toxoplasma gondii, a member of the phylum Apicomplexa. The definitive host for T. gondii is the domestic cat and other felids, in which the parasite completes its sexual cycle and produces oocysts. Intermediate hosts include a wide range of warm-blooded animals, including birds, rodents, livestock, and humans. The life cycle involves three infectious stages: tachyzoites (rapidly dividing forms), bradyzoites (slowly dividing forms contained within tissue cysts), and sporozoites (contained within sporulated oocysts). Cats become infected through ingestion of tissue cysts from intermediate hosts, ingestion of sporulated oocysts from the environment, or transplacental transmission. Following ingestion, bradyzoites or sporozoites invade intestinal epithelial cells and undergo asexual multiplication (schizogony) followed by sexual reproduction (gametogony) leading to oocyst formation. Oocysts are shed in feces, typically beginning 3 to 10 days after primary infection and continuing for 1 to 3 weeks. A single cat can shed millions of oocysts during this period. Oocysts sporulate in the environment within 1 to 5 days under favorable conditions of temperature and humidity, becoming infectious. Sporulated oocysts are highly resistant to environmental degradation and can remain viable for months to years in soil, water, and contaminated surfaces.

Epidemiology

Seroprevalence of T. gondii in domestic cat populations varies widely by geographic region, management practices, and age. Seroprevalence rates range from 10% to 60% in various studies globally. Outdoor cats that hunt have significantly higher seroprevalence compared to strictly indoor cats. Kittens and young adult cats are more likely to shed oocysts after primary infection, while older cats typically have chronic latent infections with tissue cysts and do not shed oocysts unless reinfected or immunosuppressed. The risk of environmental contamination with oocysts is highest in areas with large populations of free-roaming cats. The topic of cat toxoplasmosis baby risk is a frequent concern in veterinary public health discussions, as primary maternal infection during pregnancy can lead to congenital transmission. However, direct transmission from a pet cat to a human is rare compared to foodborne transmission via undercooked meat or contaminated produce.

Clinical Signs in Cats

Most cats infected with T. gondii remain asymptomatic. Clinical disease occurs most commonly in immunocompromised cats, including those with feline leukemia virus (FeLV) or feline immunodeficiency virus (FIV) coinfection, kittens, and cats receiving immunosuppressive therapy. Clinical signs are primarily attributable to tissue necrosis and inflammation caused by tachyzoite proliferation in various organs.

Ocular Toxoplasmosis

Ocular disease is a common manifestation in cats. Clinical signs include anterior uveitis, chorioretinitis, hyphema, and secondary glaucoma. Feline ocular toxoplasmosis often presents as unilateral or bilateral uveitis with aqueous flare, keratic precipitates, and iris hyperpigmentation. Retinal lesions appear as focal or multifocal areas of necrosis and inflammation.

Neurological Toxoplasmosis

Central nervous system involvement occurs when tachyzoites invade the brain and spinal cord. Clinical signs include ataxia, circling, head pressing, seizures, cranial nerve deficits, tremors, and behavioral changes. Focal or multifocal granulomatous meningoencephalitis is the characteristic histopathological finding. Neurological signs may be acute or progressive depending on the extent of tissue damage.

Systemic Toxoplasmosis

Disseminated infection involves multiple organ systems. Clinical signs include fever, lethargy, anorexia, weight loss, icterus, hepatomegaly, splenomegaly, pancreatitis, and lymphadenopathy. Respiratory signs such as dyspnea and tachypnea may occur due to interstitial pneumonia. Gastrointestinal signs including vomiting and diarrhea are less common but can occur with intestinal involvement.

Congenital Toxoplasmosis

Transplacental transmission in pregnant queens can result in abortion, stillbirth, or neonatal death. Kittens born alive may exhibit failure to thrive, neurological deficits, ocular lesions, or develop clinical signs within the first few weeks of life.

Pathology

Gross pathological findings in acute toxoplasmosis include multifocal necrotic foci in the liver, spleen, lungs, and lymph nodes. The liver may appear enlarged with pale, irregular foci of necrosis. Pulmonary lesions consist of diffuse interstitial pneumonia with edema and congestion. In the brain, gross lesions may be absent or appear as small, pale, or hemorrhagic foci. Histopathological examination reveals necrotizing inflammation with intracellular and extracellular tachyzoites. Tissue cysts containing bradyzoites are found in chronic infections, predominantly in skeletal muscle, myocardium, and brain. Cysts are spherical, thin-walled structures measuring 10 to 100 micrometers in diameter. The host inflammatory response is characterized by mononuclear cell infiltration, including macrophages, lymphocytes, and plasma cells.

Diagnosis

Diagnosis of feline toxoplasmosis requires a combination of serological, molecular, and histopathological methods. No single test is definitive for all clinical scenarios.

Serological Diagnosis

Serological detection of anti-T. gondii antibodies is the most common diagnostic approach. The modified agglutination test (MAT) and indirect fluorescent antibody test (IFAT) are reference methods. Commercial enzyme-linked immunosorbent assay (ELISA) kits are widely available for detection of IgM and IgG antibodies. IgM antibodies appear within 1 to 2 weeks post-infection and decline over several months. IgG antibodies appear slightly later and persist for months to years. A four-fold rise in IgG titer on paired samples collected 2 to 4 weeks apart indicates active infection. A single positive IgG titer indicates prior exposure but does not confirm active disease. Detection of IgM antibodies suggests recent or active infection, but cross-reactivity and persistence can complicate interpretation.

Molecular Diagnosis

Polymerase chain reaction (PCR) assays targeting the B1 gene or the 529 bp repetitive element of T. gondii are highly sensitive and specific. Real-time quantitative PCR (qPCR) allows quantification of parasite DNA. PCR can be performed on whole blood, aqueous humor, cerebrospinal fluid (CSF), bronchoalveolar lavage fluid, or tissue biopsies. Detection of T. gondii DNA in blood or CSF supports a diagnosis of active systemic or neurological toxoplasmosis. PCR on fecal samples can detect oocyst DNA but does not distinguish between sporulated and unsporulated oocysts.

Fecal Examination

Fecal flotation using Sheather's sugar solution or zinc sulfate centrifugation can detect oocysts. Oocysts are subspherical, measuring 10 to 12 micrometers in diameter. However, oocyst shedding is intermittent and of short duration, making fecal examination an insensitive method for diagnosis of clinical toxoplasmosis. Negative fecal examination does not rule out infection.

Histopathology and Immunohistochemistry

Tissue biopsy or necropsy specimens stained with hematoxylin and eosin can reveal tachyzoites and tissue cysts. Immunohistochemistry using anti-T. gondii antibodies provides definitive identification of the parasite in tissue sections. This method is particularly useful for confirming ocular or neurological toxoplasmosis when other tests are inconclusive.

Cytology

Cytological examination of CSF, aqueous humor, bronchoalveolar lavage fluid, or fine-needle aspirates of lymph nodes or organs may reveal tachyzoites. Tachyzoites are crescent-shaped, approximately 2 by 6 micrometers, with a prominent nucleus. Cytology has low sensitivity but high specificity when organisms are identified.

Diagnostic Algorithm

The following Mermaid diagram outlines a diagnostic decision tree for suspected feline toxoplasmosis.

flowchart TD
    A[Cat with clinical signs consistent with toxoplasmosis], > B{Serology: IgM and IgG ELISA}
    B, > C[IgM positive, IgG negative or low]
    C, > D[Active or recent infection]
    D, > E[PCR on blood, CSF, or aqueous humor]
    E, > F[PCR positive: confirm active infection]
    E, > G[PCR negative: consider other causes]
    B, > H[IgG positive, IgM negative]
    H, > I[Prior exposure, chronic infection]
    I, > J[Clinical signs likely due to other etiology]
    B, > K[IgG and IgM negative]
    K, > L[Toxoplasmosis unlikely]
    L, > M[Consider alternative diagnoses]
    B, > N[Four-fold rise in IgG on paired samples]
    N, > O[Active infection confirmed]

Treatment

Treatment is indicated for cats with clinical toxoplasmosis. The standard therapeutic regimen consists of clindamycin administered at 10 to 12 mg/kg orally every 12 hours for 4 weeks. Clindamycin is effective against tachyzoites but does not eliminate tissue cysts. Alternative therapies include trimethoprim-sulfonamide combinations (15 mg/kg every 12 hours) or azithromycin (10 mg/kg every 24 hours). Corticosteroids such as prednisolone at 1 to 2 mg/kg every 12 to 24 hours are indicated for cats with ocular or neurological inflammation to reduce immune-mediated tissue damage. Supportive care including fluid therapy, nutritional support, and management of secondary infections is essential. Treatment should continue for at least 2 weeks beyond clinical resolution.

Zoonotic Risk and Public Health Considerations

T. gondii is a zoonotic pathogen capable of infecting humans. The primary routes of human infection are ingestion of undercooked meat containing tissue cysts, ingestion of food or water contaminated with sporulated oocysts, and transplacental transmission. Direct transmission from a pet cat to its owner through casual contact is unlikely because oocysts require 1 to 5 days to sporulate after shedding. However, handling of cat litter boxes contaminated with sporulated oocysts poses a risk. Immunocompromised individuals and pregnant women are at increased risk for severe toxoplasmosis. Primary maternal infection during pregnancy can lead to congenital toxoplasmosis in the fetus, resulting in chorioretinitis, intracranial calcifications, hydrocephalus, and developmental abnormalities. The risk of cat toxoplasmosis baby transmission is a common concern, and veterinary guidance emphasizes that pregnant women should avoid cleaning litter boxes or should use gloves and wash hands thoroughly. Indoor cats that do not hunt and are fed commercial diets have a very low risk of shedding oocysts. Routine serological testing of cats for toxoplasmosis is not recommended for public health purposes because a positive IgG titer indicates prior exposure and immunity, not active shedding. Oocyst shedding occurs only during primary infection and is typically undetectable by the time seroconversion is detected.

Prevention and Control

Prevention of toxoplasmosis in cats focuses on reducing exposure to T. gondii. Cats should be kept indoors to prevent hunting of intermediate hosts. Feeding only commercially processed cooked or canned cat food eliminates ingestion of tissue cysts. Raw meat diets should be avoided. Litter boxes should be cleaned daily to remove oocysts before sporulation occurs. Litter box disinfection with boiling water or steam is effective, as oocysts are resistant to most chemical disinfectants. Gloves should be worn when handling potentially contaminated soil or cat litter. Pregnant women and immunocompromised individuals should avoid contact with cat feces. There is no licensed vaccine for toxoplasmosis in cats. Environmental management including covering sandboxes and garden areas can reduce oocyst contamination. Rodent control around the home further decreases transmission risk.

Conclusion

Toxoplasmosis in cats is a complex parasitic disease with variable clinical presentations ranging from subclinical infection to severe systemic, ocular, or neurological disease. Diagnosis requires integration of serological, molecular, and histopathological methods. Treatment with clindamycin is effective for active infection. Zoonotic risk is primarily associated with environmental contamination by oocysts, and preventive measures including indoor housing, commercial feeding, and proper litter box hygiene significantly reduce transmission. Veterinary practitioners play a critical role in educating cat owners about the biology of T. gondii and evidence-based risk mitigation strategies.

References

1. Dubey JP. Toxoplasmosis of Animals and Humans. 2nd ed. CRC Press; 2010.
2. Lappin MR. Feline toxoplasmosis. In: Greene CE, ed. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier Saunders; 2012:806-821.
3. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965-1976.
4. Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. International Journal for Parasitology. 2008;38(11):1257-1278.
5. Elmore SA, Jones JL, Conrad PA, Patton S, Lindsay DS, Dubey JP. Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention. Trends in Parasitology. 2010;26(4):190-196.
6. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. International Journal for Parasitology. 2000;30(12-13):1217-1258.
7. Dubey JP, Lindsay DS, Lappin MR. Toxoplasmosis and other intestinal coccidial infections in cats and dogs. Veterinary Clinics of North America: Small Animal Practice. 2009;39(6):1009-1034.
8. Powell CC, Lappin MR. Clinical ocular toxoplasmosis in neonatal kittens. Veterinary Ophthalmology. 2001;4(2):87-92.
9. Davidson MG, Rottman JB, English RV, Lappin MR, Tompkins MB. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. American Journal of Pathology. 1993;143(5):1486-1497.
10. Lappin MR, Burney DP, Hill SA, Spilker ME. Detection of Toxoplasma gondii-specific IgA in the aqueous humor of cats. American Journal of Veterinary Research. 1996;57(3):343-346.
11. Swinger RL, Schmidt KA, Dubielzig RR. Keratic precipitates in cats with naturally occurring toxoplasmosis. Veterinary Ophthalmology. 2009;12(4):247-252.
12. Dubey JP, Carpenter JL. Histologically confirmed clinical toxoplasmosis in cats: 100 cases (1952-1990). Journal of the American Veterinary Medical Association. 1993;203(11):1556-1566.
13. Lappin MR, Greene CE, Winston S, Toll SL, Epstein ME. Clinical feline toxoplasmosis: serologic diagnosis and therapeutic management of 15 cases. Journal of Veterinary Internal Medicine. 1989;3(3):139-143.
14. Burney DP, Lappin MR, Spilker ME, McReynolds LM. Detection of Toxoplasma gondii DNA in the aqueous humor of cats. Journal of Feline Medicine and Surgery. 1999;1(2):105-111.
15. Dubey JP. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. Journal of Parasitology. 1995;81(3):410-415.
16. Frenkel JK, Dubey JP, Miller NL. Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science. 1970;167(3919):893-896.
17. Hill DE, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clinical Microbiology and Infection. 2002;8(10):634-640.
18. Jones JL, Dubey JP. Waterborne toxoplasmosis: recent developments. Experimental Parasitology. 2010;124(1):10-25.
19. Dabritz HA, Conrad PA. Cats and Toxoplasma: implications for public health. Zoonoses and Public Health. 2010;57(1):34-52.
20. Vollaire MR, Radecki SV, Lappin MR. Seroprevalence of Toxoplasma gondii antibodies in clinically ill cats in the United States. Journal of the American Veterinary Medical Association. 2005;227(8):1295-1299.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.